Page last updated: 2024-11-05

trifluoroethanol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Trifluoroethanol: A non-aqueous co-solvent that serves as tool to study protein folding. It is also used in various pharmaceutical, chemical and engineering applications. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID6409
CHEMBL ID116675
CHEBI ID42330
SCHEMBL ID4869
MeSH IDM0021959

Synonyms (88)

Synonym
.beta.,.beta.,.beta.-trifluoroethyl alcohol
nsc 451
ai3-25486
einecs 200-913-6
brn 1733203
inchi=1/c2h3f3o/c3-2(4,5)1-6/h6h,1h
2,2,2-trifluoroethanol
ethanol,2,2,2-trifluoro
ethanol, 2,2,2-trifluoro-
trifluoroethanol
ETF ,
nsc-451
.beta.,.beta.-trifluoroethyl alcohol
2,2-trifluoroethyl alcohol
wln: q1xfff
2,2-trifluoroethanol
fluorinol 85
75-89-8
TFE ,
beta,beta,beta-trifluoroethyl alcohol
cf3ch2oh
CHEBI:42330 ,
2,2,2-trifluoroethyl alcohol
DB03226
STK260853
trifluoroethyl alcohol
2,2,2-trifluoroethanol, bioultra, for molecular biology, >=99.0% (gc)
CHEMBL116675
2,2,2-trifluoro-ethanol
T0435
AKOS000119834
NCGC00248871-01
2,2,2-trifluoroethan-1-ol
BBL008539
dtxcid401751
tox21_200905
dtxsid0021751 ,
cas-75-89-8
NCGC00258459-01
2,2,2-trifluoroethoxy
2,2,2-trifluorethanol
tfetoh
beta,beta,beta-trifluoroethanol
trifluoro ethanol
unii-8t8i76kyf1
8t8i76kyf1 ,
4-01-00-01370 (beilstein handbook reference)
ec 200-913-6
AM20100728
BP-21406
SCHEMBL4869
trifluoroethanol [mi]
beta, beta, beta-trifluoroethanol
2,2,2 trifluoroethanol
2,2,2-trifluoro -ethanol
1,1,1-trifluoro-2-ethanol
2,2,2-trifluoroethylalcohol
trifluroethanol
2,2,2,-trifluoroethanol
2,2,2 trifluoro-ethanol
2.2,2-trifluoroethanol
2.2.2-trifluoroethanol
2,2,2-tri-fluoroethanol
2,2,2-trifluroethanol
trifluorethanol
2,2,2-trifloro ethanol
2,2,2trifluoroethanol
2,2,2-trifluoro ethanol
2,2,2-trifluoroetanol
2,2,-trifluoroethanol
c2h3f3o
mfcd00004672
2,2,2-trifluoroethanol, nmr grade
J-506750
F0001-1907
2,2,2-trifluoroethanol, analytical standard, for nmr spectroscopy
2,2,2-trifluoroethanol, reagentplus(r), >=99%
2,2,2-trifluoroethanol redistilled from glass grade
VS-01941
Q2474643
BCP31089
trifluoroethanol;ethanol, 2,2,2-trifluoro-;trifluoroethyl alcohol
C93508
2,2,2-trifluoroethanole
trifluoroethylalcohol
sehaxldzjmqocz-uhfffaoysa-n
EN300-19568
SY349511

Research Excerpts

Overview

Trifluoroethanol was found to be a suitable mild solubilization agent for bacterial inclusion bodies.

ExcerptReferenceRelevance
"Trifluoroethanol was found to be a suitable mild solubilization agent for bacterial inclusion bodies. "( Recovery of bioactive protein from bacterial inclusion bodies using trifluoroethanol as solubilization agent.
Jha, D; Panda, AK; Singh, A; Upadhyay, V, 2016
)
2.11

Effects

ExcerptReferenceRelevance
"Trifluoroethanol (TFE) has been used to probe differences in the stability of the native state and in the folding pathways of the homologous cysteine protein inhibitors, human stefin A and B. "( Differences in the effects of TFE on the folding pathways of human stefins A and B.
Jerala, R; Kroon-Zitko, L; Turk, V; Virden, R; Waltho, JP; Zerovnik, E, 1999
)
1.75

Treatment

ExcerptReferenceRelevance
"On treating with trifluoroethanol (TFE) the peptide fragments undergo structural transition from a random coil to a helical conformation."( Conformational polymorphism and cellular toxicity of IAPP and beta AP domains.
Andrews, ME; Inayathullah, NM; Jayakumar, R; Malar, EJ, 2009
)
0.68

Toxicity

Various anesthetics are metabolized by different forms of cytochrome P-450. 2,2,2-trifluoroethanol (TFE) is the toxic metabolite of the anesthetic agent fluroxene. TFE accumulated to maximum serum concentrations 16 to 24 hr after TFE administration to rats.

ExcerptReferenceRelevance
" The enzymes involved in the toxic metabolic pathway have been investigated in this study."( Rat liver metabolism and toxicity of 2,2,2-trifluoroethanol.
Dunbar, D; Fraser, JM; Kaminsky, LS; Seaman, M, 1992
)
0.55
"Various anesthetics are metabolized by different forms of cytochrome P-450 yielding the same toxic metabolite, 2,2,2-trifluoroethanol (TFE)."( 2,2,2-Trifluoroethanol toxicity in aged rats.
Kaminsky, LS; Kim, JC, 1988
)
0.97
"As part of an effort to further elucidate the mechanism whereby fluorinated ether anesthetics express their various toxic effects, Golden Syrian hamsters were utilized to determine acute and subchronic toxicities of the anesthetic metabolite 2,2,2-trifluoroethanol (TFE)."( 2,2,2-Trifluoroethanol toxicity in hamsters (Mesocricetus auratus).
Kaminsky, LS; Kim, JC, 1987
)
0.93
"2,2,2-Trifluoroethanol (TFE) is the toxic metabolite of the anesthetic agent fluroxene."( Mechanism of toxicity of 2,2,2-trifluoroethanol in rats.
Fraser, JM; Kaminsky, LS; Silkworth, JB, 1986
)
1.04
"2,2,2-Trifluoroethanol (TFE), the toxic metabolite of the anesthetic agent fluoroxene, is further metabolized to trifluoroacetic acid, which accumulated to maximum serum concentrations 16 to 24 hr after TFE administration to rats."( Metabolism of 2,2,2-trifluoroethanol and its relationship to toxicity.
Fraser, JM; Kaminsky, LS, 1987
)
1.08

Dosage Studied

ExcerptRelevanceReference
"0 vol %) causes leftward shifts of the dose-response curves when applied extracellularly, and rightward shifts when added from the cytoplasmic side."( 2,2,2-Trifluoroethanol changes the transition kinetics and subunit interactions in the small bacterial mechanosensitive channel MscS.
Akitake, B; Anishkin, A; de Kruijff, B; Killian, JA; Spelbrink, RE; Sukharev, S, 2007
)
0.82
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
fluoroalcohol
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (4)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
GLI family zinc finger 3Homo sapiens (human)Potency55.77160.000714.592883.7951AID1259369; AID1259392
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency70.96660.003041.611522,387.1992AID1159552; AID1159553; AID1159555
v-jun sarcoma virus 17 oncogene homolog (avian)Homo sapiens (human)Potency63.10150.057821.109761.2679AID1159526; AID1159528
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency28.75630.000323.4451159.6830AID743065
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (5)

Assay IDTitleYearJournalArticle
AID1654567Toxicity in Wistar rat measured for 6 days2020Journal of medicinal chemistry, 06-25, Volume: 63, Issue:12
Metabolic and Pharmaceutical Aspects of Fluorinated Compounds.
AID23443Partition coefficient (logP)1985Journal of medicinal chemistry, Mar, Volume: 28, Issue:3
Use of physicochemical parameters in distance geometry and related three-dimensional quantitative structure-activity relationships: a demonstration using Escherichia coli dihydrofolate reductase inhibitors.
AID342464Dissociation constant, pKa of the compound2008Journal of medicinal chemistry, Aug-14, Volume: 51, Issue:15
The many roles for fluorine in medicinal chemistry.
AID1582364Lipophilicity, logP of the compound by 19F NMR-based method2020Journal of medicinal chemistry, 02-13, Volume: 63, Issue:3
Systematic Investigation of Lipophilicity Modulation by Aliphatic Fluorination Motifs.
AID1435044Binding affinity to d(G4C4)2 DNA major groove assessed as stabilization of A-from DNA conformation after 30 mins by CD spectroscopic method2017Bioorganic & medicinal chemistry, 02-15, Volume: 25, Issue:4
Probing A-form DNA: A fluorescent aminosugar probe and dual recognition by anthraquinone-neomycin conjugates.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (927)

TimeframeStudies, This Drug (%)All Drugs %
pre-199065 (7.01)18.7374
1990's249 (26.86)18.2507
2000's333 (35.92)29.6817
2010's248 (26.75)24.3611
2020's32 (3.45)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 50.47

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index50.47 (24.57)
Research Supply Index6.85 (2.92)
Research Growth Index4.95 (4.65)
Search Engine Demand Index82.92 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (50.47)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (0.21%)5.53%
Reviews9 (0.95%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other934 (98.84%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]